Rajesh Kumar
Stock Analyst at HSBC
(3.24)
# 1,012
Out of 4,876 analysts
21
Total ratings
60%
Success rate
13.01%
Average return
Main Sectors:
Stocks Rated by Rajesh Kumar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly and Company | Downgrades: Reduce | $1,150 → $700 | $795.12 | -11.96% | 2 | Apr 28, 2025 | |
| IQV IQVIA Holdings | Downgrades: Hold | $260 → $160 | $158.16 | +1.16% | 1 | Apr 25, 2025 | |
| KDP Keurig Dr Pepper | Upgrades: Buy | $36 → $42 | $33.04 | +27.12% | 1 | Apr 25, 2025 | |
| ABBV AbbVie | Upgrades: Buy | $185 | $186.79 | -0.96% | 3 | Jun 5, 2024 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $660 → $670 | $412.12 | +62.57% | 3 | Apr 30, 2024 | |
| DHR Danaher | Upgrades: Buy | $250 → $280 | $201.46 | +38.99% | 2 | Apr 17, 2024 | |
| UNH UnitedHealth Group | Upgrades: Hold | $460 | $302.62 | +52.01% | 2 | Apr 4, 2024 | |
| TEVA Teva Pharmaceutical Industries | Initiates: Buy | $13 | $16.56 | -21.50% | 1 | Dec 18, 2023 | |
| BMY Bristol-Myers Squibb Company | Upgrades: Hold | $55 → $53 | $46.65 | +13.61% | 2 | Oct 27, 2023 | |
| MRNA Moderna | Initiates: Reduce | $97 | $27.54 | +252.21% | 1 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $124 | $106.14 | +16.83% | 1 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $24.24 | +106.27% | 1 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $123 | $78.83 | +56.03% | 1 | Jul 14, 2023 |
Eli Lilly and Company
Apr 28, 2025
Downgrades: Reduce
Price Target: $1,150 → $700
Current: $795.12
Upside: -11.96%
IQVIA Holdings
Apr 25, 2025
Downgrades: Hold
Price Target: $260 → $160
Current: $158.16
Upside: +1.16%
Keurig Dr Pepper
Apr 25, 2025
Upgrades: Buy
Price Target: $36 → $42
Current: $33.04
Upside: +27.12%
AbbVie
Jun 5, 2024
Upgrades: Buy
Price Target: $185
Current: $186.79
Upside: -0.96%
Thermo Fisher Scientific
Apr 30, 2024
Maintains: Buy
Price Target: $660 → $670
Current: $412.12
Upside: +62.57%
Danaher
Apr 17, 2024
Upgrades: Buy
Price Target: $250 → $280
Current: $201.46
Upside: +38.99%
UnitedHealth Group
Apr 4, 2024
Upgrades: Hold
Price Target: $460
Current: $302.62
Upside: +52.01%
Teva Pharmaceutical Industries
Dec 18, 2023
Initiates: Buy
Price Target: $13
Current: $16.56
Upside: -21.50%
Bristol-Myers Squibb Company
Oct 27, 2023
Upgrades: Hold
Price Target: $55 → $53
Current: $46.65
Upside: +13.61%
Moderna
Jul 14, 2023
Initiates: Reduce
Price Target: $97
Current: $27.54
Upside: +252.21%
Jul 14, 2023
Initiates: Buy
Price Target: $124
Current: $106.14
Upside: +16.83%
Jul 14, 2023
Initiates: Buy
Price Target: $50
Current: $24.24
Upside: +106.27%
Jul 14, 2023
Initiates: Hold
Price Target: $123
Current: $78.83
Upside: +56.03%